术前乳腺MRI:外科医生患者选择模式及结局分析中的潜在偏倚
该研究通过问卷调查评估乳腺外科与普外科医生对初诊乳腺癌患者术前乳腺MRI转诊的影响因素。289份调查显示,BRCA突变、腋窝淋巴结受累等高风险因素转诊可能性较高,乳腺外科总体转诊评分高于普外科,提示选择偏倚可能影响结局分析。
要点
- BRCA突变、腋窝淋巴结受累、乳腺X线隐匿病灶是术前MRI转诊的高权重因素。
- 乳腺外科较普外科更常转诊(4.32 vs 3.92,p=0.03),尤其BRCA突变与小肿瘤。
- 普外科较乳腺外科更常为多灶/多中心病变转诊(5.44 vs 5.02,p=0.001)。
核心结论
- 术前乳腺MRI转诊与特定高风险患者、肿瘤及临床因素相关,且在乳腺外科与普外科医生队列间不一致,选择偏倚可能影响术前乳腺MRI的结局分析。
研究设计与样本
- 调查研究:2014年6月16日至8月11日向行乳腺手术的外科医生发放问卷,289份回复(乳腺外科154名,53%;普外科135名,47%),采用1-7 Likert评分,线性混合模型比较,p≤0.05为显著。
诊断标准与关键数值
- 转诊可能性均值:BRCA突变6.17,腋窝淋巴结受累6.22,乳腺X线隐匿肿瘤5.62,胸肌固定5.49,新辅助候选5.38,家族史5.33,极高密度乳腺5.30。
- 转诊可能性均值:患者为乳房切除候选但要求保乳5.27,年龄<40岁5.24,多灶/多中心5.22,浸润性小叶癌5.20,放射科建议5.19,个人乳腺癌史5.10。
- 转诊可能性均值:三阴性乳腺癌4.66,T3肿瘤4.48,T2肿瘤4.41。
- 乳腺外科 vs 普外科:总体4.32 vs 3.92(p=0.03);BRCA突变6.39 vs 5.93(p=0.01);肿瘤<1 cm 3.84 vs 3.40(p=0.002);多灶/多中心5.02 vs 5.44(p=0.001)。
临床应用与阅片要点
- 外科医生对高风险因素(BRCA突变、腋窝淋巴结受累)更倾向于转诊术前乳腺MRI,阅片时需了解转诊选择的不统一。
- 乳腺外科与普外科医生对多灶/多中心病变的转诊倾向存在差异,可能影响病例构成。
局限性
- 结论指出选择偏倚可能影响术前乳腺MRI的结局分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to determine which patient- and tumor-related and clinical variables influence dedicated breast surgeons' and general surgeons' referrals for preoperative breast MRI for patients with newly diagnosed breast cancer.
MATERIALS AND METHODS: Surgeons who perform breast surgery responded to a survey from June 16, 2014, through August 11, 2014. Participants self-identified as breast or general surgeons and provided professional practice details. They used Likert scores (range, 1-7 with increasing likelihood to order MRI) to weigh numerous patient- and tumor-related and clinical variables. Mean likelihood scores were calculated and compared using a linear mixed model. A p ≤ 0.05 was considered statistically significant.
RESULTS: Two hundred eighty-nine surveys from 154 (53%) breast surgeons and 135 (47%) general surgeons showed an overall likelihood to refer for patients with a BRCA mutation (mean Likert score, 6.17), familial (mean Likert score, 5.33) or personal (mean Likert score, 5.10) breast cancer history, extremely dense breasts (mean Likert score, 5.30), age younger than 40 years (mean Likert score, 5.24), axillary nodal involvement (mean Likert score, 6.22), tumor that is mammographically occult (mean Likert score, 5.62) or fixed to the pectoralis (mean Likert score, 5.49), tumor that is a candidate for neoadjuvant treatment (mean Likert score, 5.38), multifocal or multicentric disease (mean Likert score, 5.22), invasive lobular carcinoma (mean Likert score, 5.20), T3 (mean Likert score, 4.48) or T2 (mean Likert score, 4.41) tumor, triple-negative breast cancer (mean Likert score, 4.66), a patient who is a candidate for mastectomy requesting breast conservation therapy (mean Likert score, 5.27), and radiologists' recommendations (mean Likert score, 5.19). Across all patient ages, breast surgeons referred more often than did general surgeons (mean Likert score, 4.32 vs 3.92; p = 0.03), especially for patients with BRCA mutation (mean Likert score, 6.39 vs 5.93; p = 0.01) and tumors smaller than 1 cm (mean Likert score, 3.84 vs 3.40; p = 0.002). Breast surgeons referred less often than did general surgeons for multifocal or multicentric disease (mean Likert score, 5.02 vs 5.44; p = 0.001). Breast surgeons and general surgeons similarly weighed other variables.
CONCLUSION: Preoperative breast MRI referral trended with certain higher risk patient- and tumor-related and clinical variables and were nonuniform between the breast surgeons and general surgeon cohorts. Selection bias could affect outcomes analyses for preoperative breast MRI.
引用
- Lee J, Tanaka E, Eby PR, et al. Preoperative Breast MRI: Surgeons' Patient Selection Patterns and Potential Bias in Outcomes Analyses. AJR Am J Roentgenol. 2016. PMID: 28026205. doi:10.2214/AJR.16.17038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。